Roche v. Aetna Inc., et al.

Summary

The United States District Court for the District of New Jersey considers defendants’ motion to dismiss Michelle Roche’s amended complaint concerning Aetna’s and Rawlings’s subrogation and reimbursement demands for health benefits paid after a car accident. The court holds that the claims are not clearly barred by the statute of limitations or voluntary payment doctrine and declines to dismiss any defendants at the pleading stage. It dismisses claims based directly on N.J.S.A. § 2A:15-97 and N.J.A.C. § 11:4-42.10 because those provisions do not create an implied private right of action, while allowing Roche’s breach-of-contract claims to proceed.

Holdings

1. The statute-of-limitations defense could not be resolved on the pleadings because the complaint did not establish when the claims accrued or plead facts that placed Roche out of court.
2. The voluntary payment doctrine did not warrant dismissal because the complaint did not establish that Roche's payment was voluntary and made without mistake of fact, fraud, duress, or extortion.
3. All named defendants remained proper parties at the pleading stage.
4. N.J.S.A. § 2A:15-97 and N.J.A.C. § 11:4-42.10 applied to the dispute and prohibited Aetna's asserted subrogation claim against Roche.
5. Neither the collateral-source statute nor the anti-subrogation regulation creates an express or implied private cause of action for Roche.
6. The complaint plausibly stated claims for breach of contract, breach of the implied covenant of good faith and fair dealing, bad faith, breach of fiduciary duty, violation of the Consumer Fraud Act, intentional misrepresentation, conversion, and unjust enrichment, but failed to state claims for directing or permitting another's conduct, acting in concert, or theft by deception.

Questions Presented

1. Whether the complaint established on its face that Roche's claims were barred by the applicable six-year statute of limitations.
2. Whether the voluntary payment doctrine required dismissal at the pleading stage.
3. Whether the non-administering Aetna entities and Rawlings were proper parties before discovery.
4. Whether New Jersey's collateral-source statute, N.J.S.A. § 2A:15-97, and anti-subrogation regulation, N.J.A.C. § 11:4-42.10, applied to the asserted subrogation claim.
5. Whether those provisions created an implied private right of action.
6. Whether Roche plausibly stated claims for breach of contract, breach of the implied covenant of good faith and fair dealing, bad faith, breach of fiduciary duty, consumer fraud, intentional misrepresentation, conversion, and unjust enrichment.
7. Whether Roche stated claims based on directing or permitting another's conduct, acting in concert, and theft by deception.

Disposition

other